A health-care worker holds up a vial of the AstraZeneca Covishield vaccine at a COVID-19 vaccination clinic in Montreal, Thursday, March 18, 2021. THE CANADIAN PRESS/Paul Chiasson

A health-care worker holds up a vial of the AstraZeneca Covishield vaccine at a COVID-19 vaccination clinic in Montreal, Thursday, March 18, 2021. THE CANADIAN PRESS/Paul Chiasson

PHAC receives first report of blood clot linked to AstraZeneca

The federal agency says the person is now recovering at home

The Public Health Agency of Canada says it has received a report of an adverse event involving blood clots after someone in Canada received the Oxford-AstraZeneca vaccine.

This is the first such reported case in Canada.

The federal agency says the person is now recovering at home.

The vaccine was the one produced at the Serum Institute of India, known as Covishield.

More Coming.

The Canadian Press

Coronavirusvaccines

Be Among The First To Know

Sign up for a free account today, and receive top headlines in your inbox Monday to Saturday.

Sign Up with google Sign Up with facebook

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Reset your password

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

A link has been emailed to you - check your inbox.



Don't have an account? Click here to sign up